The ongoing conflict in the Middle East is causing significant disruptions to critical medical supplies in Canada, specifically impacting the availability of helium for healthcare services.

Helium Supply Reduced for Canadian Healthcare

Saskatchewan is the latest province to experience the effects, reporting a 50 percent reduction in liquid helium allocations from its supplier. This essential element is vital for the operation of Magnetic Resonance Imaging (MRI) machines, which are crucial for patient diagnosis and treatment.

Supply Chain Vulnerabilities Highlighted

While the immediate impact on patient care is being managed, the situation underscores a long-standing vulnerability in Canada's medical supply chains. Experts warn that Canada has not taken adequate measures to ensure a secure supply of these vital resources, despite previous warnings and supply chain issues.

Geopolitical Instability Drives Shortage

The crisis stems from a combination of geopolitical instability and disruptions to global supply chains. Strikes by Iran on Gulf states in early March led to the shutdown of a major liquefied natural gas terminal operated by QatarEnergy.

Qatar is a leading global supplier of liquid helium, which is a byproduct of natural gas processing. QatarEnergy’s force majeure declaration, citing circumstances beyond its control, has prompted similar actions from other suppliers, including Air Liquide, a major liquid helium distributor in Canada.

Further Complications in Global Shipping

Air Liquide has also declared force majeure, announcing supply cuts and price increases. The situation is further complicated by the potential closure of the Strait of Hormuz, which has caused delays in the shipment of active pharmaceutical ingredients (APIs), essential for medication manufacturing. The Canadian Generic Pharmaceutical Association has expressed concern over these increased costs.

Mitigation Efforts and Calls for Domestic Production

HealthPro Canada, a non-profit organization, is working to push back against price hikes and assess client needs to prioritize supplies. Anne Snowdon, scientific director and CEO of the Supply Chain Advancement Network in Health, points to the lack of a single agency responsible for managing and preparing for product shortages within Canada’s healthcare system.

The Canadian health system experiences approximately 3,000 separate shortages annually. Genevieve Seabrook’s Canadian Helium Users Group is advocating for increased investment in domestic helium purification and liquefaction capabilities, as most Canadian-extracted helium is currently shipped to the United States for processing.

The federal government has previously allocated funds to address drug shortages, demonstrating the seriousness of the issue. A multi-faceted approach is needed to enhance Canada’s preparedness and ensure the continuous availability of critical medical supplies.